Mannitol upregulates monocyte HLA-DR, monocyte and neutrophil CD11b, and inhibits neutrophil apoptosis

Inflammation

Volumn 31, Issue 2, 2008, Pages 74-83

  Turina, Matthias ^a,b   Mulhall, Aaron ^a,b   Gardner, Sarah ^a,b   Polk Jr , Hiram C ^a,b   Miller, Frederick N ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

Apoptosis; CD11b; HLA DR; Mannitol; Monocyte; Neutrophil

Indexed keywords

CD11B ANTIGEN; ENDOTOXIN; HLA DR ANTIGEN; INTERLEUKIN 6; MANNITOL; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MONOCYTE; NEUTROPHIL; UPREGULATION;

ADULT; ANTIGENS, CD11B; APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CONTAMINATION; ENDOTOXINS; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-6; MANNITOL; MONOCYTES; NEUTROPHILS; SODIUM CHLORIDE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 40749096509     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-007-9051-1     Document Type: Article

References (52)

1. Pitkaenen, E., A. Pitkaenen, and J. Perheentupa. 1964. Polyhydric alcohols in human urine. Ann Med. Exp. Biol. Fenn. 42:65-71.
2. Wick, A. N., T. N. Morita, and L. Joseph. 1954. The oxidation of mannitol. Proc. Soc. Exp. Biol. Med. 85:188-190.
3. Smith, W. W., N. Finkelstein, and H. W. Smith. 1940. Renal excretion of hexitols and their derivatives and of endogenous creatinin-like chromogen in dog and man. J. Biol. Chem. 135:231-250.
4. Wakai, A., I. Roberts, G. Schierhout, and A. Wakai. 2005. Mannitol for acute traumatic brain injury. Cochrane. Database. Syst. Rev. CD001049.
5. Devaraj, S., S. K. Venugopal, U. Singh, and I. Jialal. 2005. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 54:85-91.
6. Morohoshi, M., K. Fujisawa, I. Uchimura, and F. Numano. 1995. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. N. Y. Acad. Sci. 748:562-570.
7. Morohoshi, M., K. Fujisawa, I. Uchimura, and F. Numano. 1996. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45:954-959.
8. Vulcano, M., M. F. Rosa, I. Breyer, and M. A. Isturiz. 1998. Hydroxyl radical scavengers inhibit TNF-alpha production in mononuclear cells but not in polymorphonuclear leukocytes. Int. J. Immunopharmacol. 20:709-722.
9. Perner, A., S. E. Nielsen, and J. Rask-Madsen. 2003. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med. 29:642-645.
10. Hansson, M., A. Asea, U. Ersson, S. Hermodsson, and K. Hellstrand. 1996. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J. Immunol. 156:42-47.
11. Liu, Y. J., A. Saini, D. J. Cohen, and B. S. Ooi. 1995. Modulation of macrophage proliferation by hyperglycemia. Mol. Cell Endocrinol. 114:187-192.
12. Moloney, E. D., S. Griffin, C. M. Burke, L. W. Poulter, and S. O'Sullivan. 2003. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir. Med. 97:928-932.
13. Cendoroglo, M., S. Sundaram, B. L. Jaber, and B. J. Pereira. 1998. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am. J. Kidney Dis. 31:273-282.
14. Turina, M., F. Miller, C. Tucker, and H. C. Polk, Jr. 2006. The Effects of Hyperglycemia, Hyperinsulinemia, and Hyperosmolarity on Neutrophil Apoptosis. Surg. Infect. (Larchmt) 7:111-121.
15. McNamee, J. P., P. V. Bellier, B. C. Kutzner, and R. C. Wilkins. 2005. Effect of pro-inflammatory cytokines on spontaneous apoptosis in leukocyte sub-sets within a whole blood culture. Cytokine. 31:161-167.
16. Lee, A., M. K. Whyte, and C. Haslett. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54:283-288.
17. Ruiz, L. M., G. Bedoya, J. Salazar, O. D. Garcia de, and P. J. Patino. 2002. Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species. Inflammation. 26:215-222.
18. Barclay, A. N., and M. H. Brown. 1997. The Leukocyte Antigens Facts Book, 2nd ed. New York, NY: Academic Press.
19. Ross, G. D. 2000. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit Rev. Immunol. 20:197-222.
20. Ross, G. D., and V. Vetvicka. 1993. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol. 92:181-184.
21. Berton, G., C. Laudanna, C. Sorio, and F. Rossi. 1992. Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. J. Cell Biol. 116:1007-1017.
22. Laurent, F., A. M. Benoliel, C. Capo, and P. Bongrand. 1991. Oxidative metabolism of polymorphonuclear leukocytes: modulation by adhesive stimuli. J. Leukoc. Biol. 49:217-226.
23. Nathan, C., S. Srimal, C. Farber, E. Sanchez, L. Kabbash, A. Asch, J. Gailit, and S. D. Wright. 1989. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J. Cell Biol. 109:1341-1349.
24. Rosales, C., and JulianoR. L. 1995. Signal transduction by cell adhesion receptors in leukocytes. J. Leukoc. Biol. 57:189-198.
25. Shappell, S. B., C. Toman, D. C. Anderson, A. A. Taylor, M. L. Entman, and C. W. Smith. 1990. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J. Immunol. 144:2702-2711.
26. Zhou, X., X. P. Gao, J. Fan, Q. Liu, K. N. Anwar, R. S. Frey, and A. B. Malik. 2005. LPS activation of Toll-like receptor 4 signals CD11b/CD18 expression in neutrophils. Am J. Physiol Lung Cell Mol. Physiol. 288:L655-L662.
27. Lin, R. Y., M. E. Astiz, J. C. Saxon, and E. C. Rackow. 1993. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest. 104:847-853.
28. McLeish, K. R., S. R. Wellhausen, and W. L. Dean. 1987. Biochemical basis of HLA-DR and CR3 modulation on human peripheral blood monocytes by lipopolysaccharide. Cell Immunol. 108:242-248.
29. Yan, S. R., K. Sapru, and A. C. Issekutz. 2004. The CD11/CD18 (beta2) integrins modulate neutrophil caspase activation and survival following TNF-alpha or endotoxin induced transendothelial migration. Immunol. Cell Biol. 82:435-446.
30. Benacerraf, B. 1981. Role of MHC gene products in immune regulation. Science. 212:1229-1238.
31. McDevitt, H. O. 1980. Regulation of the immune response by the major histocompatibility system. N. Engl. J. Med. 303:1514-1517.
32. De Groote, D., P. F. Zangerle, Y. Gevaert, M. F. Fassotte, Y. Beguin, F. Noizat-Pirenne, J. Pirenne, R. Gathy, M. Lopez, and I. Dehart. 1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 4:239-248.
33. Turina, M., D. E. Fry, and H. C. Polk, Jr. 2005. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 33:1624-1633.
34. Lau, D., H. Mollnau, J. P. Eiserich, B. A. Freeman, A. Daiber, U. M. Gehling, J. Brummer, V. Rudolph, T. Munzel, T. Heitzer, T. Meinertz, and S. Baldus. 2005. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc. Natl. Acad. Sci. U.S.A 102:431-436.
35. Lynam, E. B., S. I. Simon, Y. P. Rochon, and L. A. Sklar. 1994. Lipopolysaccharide enhances CD11b/CD18 function but inhibits neutrophil aggregation. Blood. 83:3303-3311.
36. Kaupke, C. J., J. Zhang, D. Rajpoot, J. Wang, X. J. Zhou, and N. D. Vaziri. 1996. Effects of conventional peritoneal dialysates on leukocyte adhesion and CD11b, CD18 and CD14 expression. Kidney Int. 50:1676-1683.
37. Rizoli, S. B., S. G. Rhind, P. N. Shek, K. Inaba, D. Filips, H. Tien, F. Brenneman, and O. Rotstein. 2006. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg. 243:47-57.
38. Harris, E. S., T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2000. The leukocyte integrins. J. Biol. Chem. 275:23409-23412.
39. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56:672-686.
40. Salas, A., M. Shimaoka, S. Chen, C. V. Carman, and T. Springer. 2002. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1. J Biol. Chem. 277:50255-50262.
41. Calderwood, D. A. 2004. Integrin activation. J Cell Sci. 117:657-666.
42. Hershman, M. J., W. G. Cheadle, S. R. Wellhausen, P. F. Davidson, and H. C. Polk, Jr. 1990. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br. J. Surg. 77:204-207.
43. Schinkel, C., R. Sendtner, S. Zimmer, and E. Faist. 1998. Functional analysis of monocyte subsets in surgical sepsis. J. Trauma. 44:743-748.
44. Hershman, M. J., S. H. Appel, S. R. Wellhausen, G. Sonnenfeld, and H. C. Polk, Jr. 1989. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin. Exp. Immunol. 77:67-70.
45. Dries, D. J., G. J. Jurkovich, R. V. Maier, T. P. Clemmer, S. N. Struve, J. A. Weigelt, G. G. Stanford, D. L. Herr, H. R. Champion, and F. R. Lewis. 1994. Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch. Surg. 129:1031-1041.
46. Polk, H. C., Jr., W. G. Cheadle, D. H. Livingston, J. L. Rodriguez, K. M. Starko, A. E. Izu, H. S. Jaffe, and G. Sonnenfeld. 1992. A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am. J. Surg. 163:191-196.
47. Cruz, J., G. Minoja, K. Okuchi, and E. Facco. 2004. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J. Neurosurg. 100:376-383.
48. Livingston, D. H., S. H. Appel, S. R. Wellhausen, G. Sonnenfeld, and H. C. Polk, Jr. 1988. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch. Surg. 123:1309-1312.
49. Volk, H. D., P. Reinke, D. Krausch, H. Zuckermann, K. Asadullah, J. M. Muller, W. D. Docke, and W. J. Kox. 1996. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 22(Suppl 4):S474-S481.
50. Ogden, A. T., S. A. Mayer, and E. S. Connolly, Jr. 2005. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery. 57:207-215.
51. Gosselin, E. J., K. Wardwell, W. F. Rigby, and P. M. Guyre. 1993. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 151:1482-1490.
52. Reinisch, W., C. Lichtenberger, G. Steger, W. Tillinger, O. Scheiner, A. Gangl, D. Maurer, and M. Willheim. 2003. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin. Exp. Immunol. 133:476-484.